Modern Chinese Medicine Group Co., Ltd.
HKEX:1643.HK
0.51 (HKD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q3 | 2019 Q4 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 177.158 | 203.674 | 228.446 | 236.753 | 228.627 | 206.145 | 89.854 | 60.877 | 45.797 |
| Cost of Revenue
| 128.754 | 137.031 | 134.038 | 132.818 | 132.321 | 112.2 | 51.227 | 33.834 | 27.155 |
| Gross Profit
| 48.403 | 66.644 | 94.408 | 103.934 | 96.306 | 93.945 | 38.627 | 27.043 | 18.642 |
| Gross Profit Ratio
| 0.273 | 0.327 | 0.413 | 0.439 | 0.421 | 0.456 | 0.43 | 0.444 | 0.407 |
| Reseach & Development Expenses
| 1.621 | 0 | 1.683 | 1.811 | 0 | 0 | 0 | 0 | 2.425 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 27.795 | -4.541 | 5.381 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 4.991 | 1.835 | 1.531 |
| SG&A
| 17.317 | 20.171 | 23.329 | 20.918 | 31.432 | 21.902 | 32.786 | -2.706 | 6.912 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0.153 | -0.001 | 0 |
| Operating Expenses
| 18.937 | 20.171 | 25.012 | 22.729 | 31.432 | 21.902 | 21.152 | 8.928 | 10.069 |
| Operating Income
| 29.466 | 46.473 | 69.396 | 81.205 | 64.873 | 72.042 | 17.668 | 18.141 | 8.626 |
| Operating Income Ratio
| 0.166 | 0.228 | 0.304 | 0.343 | 0.284 | 0.349 | 0.197 | 0.298 | 0.188 |
| Total Other Income Expenses Net
| 1.918 | -2.076 | -5.682 | 0.354 | 0.52 | 0.184 | -0.064 | -0.065 | 0.001 |
| Income Before Tax
| 31.384 | 44.397 | 63.714 | 81.559 | 65.394 | 72.226 | 17.604 | 18.076 | 8.627 |
| Income Before Tax Ratio
| 0.177 | 0.218 | 0.279 | 0.344 | 0.286 | 0.35 | 0.196 | 0.297 | 0.188 |
| Income Tax Expense
| 8.464 | 13.205 | 21.172 | 21.284 | 19.818 | 19.285 | 6.798 | 5.224 | 3.315 |
| Net Income
| 22.919 | 31.192 | 42.541 | 60.275 | 45.576 | 52.941 | 10.806 | 12.852 | 5.312 |
| Net Income Ratio
| 0.129 | 0.153 | 0.186 | 0.255 | 0.199 | 0.257 | 0.12 | 0.211 | 0.116 |
| EPS
| 0.038 | 0.052 | 0.071 | 0.1 | 0.076 | 0.088 | 0 | 0 | 0 |
| EPS Diluted
| 0.038 | 0.052 | 0.071 | 0.1 | 0.076 | 0.088 | 0 | 0 | 0 |
| EBITDA
| 33.049 | 50.006 | 72.677 | 84.546 | 66.816 | 73.384 | 18.16 | 18.141 | 9.019 |
| EBITDA Ratio
| 0.187 | 0.246 | 0.318 | 0.357 | 0.292 | 0.356 | 0.202 | 0.298 | 0.197 |